HETEROARYL UREA DERIVATIVE USEFUL FOR INHIBITING CHK1

PROBLEM TO BE SOLVED: To provide substituted urea compounds useful in treatment of diseases and conditions related to DNA damage or lesions in DNA replication. SOLUTION: A compound represented by formula (I) is provided. Pharmaceutical compositions comprising the compound or a pharmaceutically permi...

Full description

Saved in:
Bibliographic Details
Main Authors OOI HUA CHEE, THORSETT EUGENE D, STAPPENBECK FRANK, COOK ADAM WADE, RUDOLPH ALEXANDER, DIAZ FRANK, GAUDINO JOHN JOSEPH, FISHER KIMBA L, FAROUZ FRANCINE S, HOLCOMB RYAN C, KESICKI EDWARD A
Format Patent
LanguageEnglish
Published 08.10.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PROBLEM TO BE SOLVED: To provide substituted urea compounds useful in treatment of diseases and conditions related to DNA damage or lesions in DNA replication. SOLUTION: A compound represented by formula (I) is provided. Pharmaceutical compositions comprising the compound or a pharmaceutically permissible salt, and a pharmaceutically permissible diluent or carrier, are also provided. COPYRIGHT: (C)2010,JPO&INPIT
AbstractList PROBLEM TO BE SOLVED: To provide substituted urea compounds useful in treatment of diseases and conditions related to DNA damage or lesions in DNA replication. SOLUTION: A compound represented by formula (I) is provided. Pharmaceutical compositions comprising the compound or a pharmaceutically permissible salt, and a pharmaceutically permissible diluent or carrier, are also provided. COPYRIGHT: (C)2010,JPO&INPIT
Author KESICKI EDWARD A
OOI HUA CHEE
STAPPENBECK FRANK
FISHER KIMBA L
COOK ADAM WADE
RUDOLPH ALEXANDER
FAROUZ FRANCINE S
THORSETT EUGENE D
GAUDINO JOHN JOSEPH
DIAZ FRANK
HOLCOMB RYAN C
Author_xml – fullname: OOI HUA CHEE
– fullname: THORSETT EUGENE D
– fullname: STAPPENBECK FRANK
– fullname: COOK ADAM WADE
– fullname: RUDOLPH ALEXANDER
– fullname: DIAZ FRANK
– fullname: GAUDINO JOHN JOSEPH
– fullname: FISHER KIMBA L
– fullname: FAROUZ FRANCINE S
– fullname: HOLCOMB RYAN C
– fullname: KESICKI EDWARD A
BookMark eNrjYmDJy89L5WQw9XANcQ3ydwyK9FEIDXJ1VHBxDfIMcwzxDHNVCA12dQv1UXDzD1Lw9PPwdPIM8fRzV3D28DbkYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBgaWRkbmZhZGjsZEKQIARqMp4A
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID JP2009227682A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2009227682A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:59:27 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2009227682A3
Notes Application Number: JP20090122107
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091008&DB=EPODOC&CC=JP&NR=2009227682A
ParticipantIDs epo_espacenet_JP2009227682A
PublicationCentury 2000
PublicationDate 20091008
PublicationDateYYYYMMDD 2009-10-08
PublicationDate_xml – month: 10
  year: 2009
  text: 20091008
  day: 08
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies ICOS CORP
RelatedCompanies_xml – name: ICOS CORP
Score 2.7491653
Snippet PROBLEM TO BE SOLVED: To provide substituted urea compounds useful in treatment of diseases and conditions related to DNA damage or lesions in DNA replication....
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HETEROARYL UREA DERIVATIVE USEFUL FOR INHIBITING CHK1
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091008&DB=EPODOC&locale=&CC=JP&NR=2009227682A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNp6JOJYj0rVi7duseinRtaju3rsx2zKeRrBmI0A1X8d_3Glbd097CBS4_4Lu7L8ldAB7EwsqEwboqnwskKEY2V612pquMmRzhlHXMrDzvGEbtIDX6U3Nag88qF0bWCf2RxRERUXPEeyHt9er_EMuTbyvXj_wDRctnP7E9pWLH3bJWjeL1bBqPvJGruK7dj5VoLPt0HWNr3dmDfYyjOyUc6KRXpqWstn2KfwIHMarLi1OoibwBR2719VoDDoebG29sbsC3PgMzoBh7jpzx-4CkY-oQD0nYxEnCCSXpG_XTAUFKR8IoCHthEkYvxA1en87h3qeJG6g4_uxvtbN-vDXX1gXU82UuLoEsGNotjfOM8YXRYswSHc20ynKmGsrb2hU0dyi63tnbhGN5SyLftt1Avfj6FrfobAt-JzfpF2CBfm4
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaPiR2PM3hbn2GA8EDO2zg3GWHAj-kRaVhJjMojM-O97a0B54qlNm1w_kt-1v7vrFeBBzK1MGKyj8plAgmJkM9VqZbrKmMkRTlnbzEp7xzBq-anRfzPfKvC5eQsj84T-yOSIiKgZ4r2Q-nr5b8RyZWzl6pF_YNPi2Uu6rrJhx50yV43i9ro0HrkjR3Gcbj9WorHs03W8W-v2Huxj2S7hQCe98lnKcvtM8Y7hIEZxeXECFZHXoeZsvl6rw-Fw7fHG6hp8q1MwfYp3z5E9fg9JOqY2cZGETewkmFCSvlIvDQlSOhJEftALkiB6IY4_eDqDe48mjq_i-NO_1U778dZcm-dQzRe5uAAyZ6i3NM4zxudGkzFLtDXTKtOZatje0i6hsUPQ1c7eO6j5yTCchkE0aMCR9JjIOLdrqBZf3-IGD96C38oN-wV5roFh
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HETEROARYL+UREA+DERIVATIVE+USEFUL+FOR+INHIBITING+CHK1&rft.inventor=OOI+HUA+CHEE&rft.inventor=THORSETT+EUGENE+D&rft.inventor=STAPPENBECK+FRANK&rft.inventor=COOK+ADAM+WADE&rft.inventor=RUDOLPH+ALEXANDER&rft.inventor=DIAZ+FRANK&rft.inventor=GAUDINO+JOHN+JOSEPH&rft.inventor=FISHER+KIMBA+L&rft.inventor=FAROUZ+FRANCINE+S&rft.inventor=HOLCOMB+RYAN+C&rft.inventor=KESICKI+EDWARD+A&rft.date=2009-10-08&rft.externalDBID=A&rft.externalDocID=JP2009227682A